RHODES PHARMS FDA Approval ANDA 209369

ANDA 209369

RHODES PHARMS

FDA Drug Application

Application #209369

Application Sponsors

ANDA 209369RHODES PHARMS

Marketing Status

None (Tentative Approval)001
None (Tentative Approval)002
None (Tentative Approval)003

Application Products

002TABLET;ORAL75MG0TAPENTADOL HYDROCHLORIDETAPENTADOL HYDROCHLORIDE
003TABLET;ORAL100MG0TAPENTADOL HYDROCHLORIDETAPENTADOL HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1TA2017-09-14STANDARD

Submissions Property Types

ORIG1Null31

CDER Filings

RHODES PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 209369
            [companyName] => RHODES PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"TAPENTADOL HYDROCHLORIDE","activeIngredients":"TAPENTADOL HYDROCHLORIDE","strength":"50MG","dosageForm":"TABLET;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"TAPENTADOL HYDROCHLORIDE","activeIngredients":"TAPENTADOL HYDROCHLORIDE","strength":"75MG","dosageForm":"TABLET;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"TAPENTADOL HYDROCHLORIDE","activeIngredients":"TAPENTADOL HYDROCHLORIDE","strength":"100MG","dosageForm":"TABLET;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"09\/14\/2017","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2017-09-14
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.